Performance of three clinical scores for steatosis and steatohepatitis and their interaction with metabolic syndrome in obese individuals

20260 citationsJournal Articlediamond Open Access

Authors

Giovani Schulte Farina · Harvard University

Bárbara Brambilla · Universidade de Caxias do Sul

Emanuelle Mendonça Pandolfo · Universidade de Caxias do Sul

Laura Kalil Nader Lazzaretti · Universidade de Caxias do Sul

Stéfano Mateus Schio Kuiava · Universidade de Caxias do Sul

Ana Maria Graciolli · Universidade de Caxias do Sul

Vitória Maria Kriger

Abstract

NLFS, HSI, and FLI show limited accuracy in obese individuals. Adjusting thresholds improves performance. Diagnostic utility remains consistent regardless of MetS, supporting their use across the MASLD spectrum.

Topics & Keywords

Liver Disease Diagnosis and Treatment Diabetes, Cardiovascular Risks, and Lipoproteins Cardiovascular Function and Risk Factors

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: World Journal of Hepatology

Volume 18, Issue 2, pp. 111962-111962

DOI: 10.4254/wjh.v18.i2.111962

Field-Weighted Citation Impact: 0.00